Selective β3 Adrenergic Receptor Agonist CL316,243 Increases the Blood Concentrations of Free Fatty Acids and GDF15
{{output}}
β3 adrenergic receptor (β3AR) agonists were originally developed to overcome obesity. Administration of selective β3AR agonist CL316,243 induces lipolysis and elevates the blood concentrations of growth differentiation factor 15 (GDF15), which exerts appeti... ...
